139 results
Page 4 of 7
425
EX-2.1
j9hkmoi1d15rza57i1
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
yh56wsoz0xba
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
8-K
kim94f ucdj5ttth1yr
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.1
pzl1 bg3qi7k9rf
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.2
u08 f9sunm9
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
c5qrp5srmpzvyp2eo7
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
8-K
EX-99.1
8mlawc4k88svt w3ju
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
DEFA14A
18rj o96m1
11 Sep 20
Additional proxy soliciting materials
7:00am
DEF 14A
i63vlbj 3hvkt
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
vi6y7ks95cpaj3
10 Aug 20
Preliminary proxy
12:00am
424B5
jaz16y
7 Jul 20
Prospectus supplement for primary offering
4:32pm
10-K
EX-10.3
tkw g1l0djdwtk6j
29 Jun 20
Annual report
4:02pm
10-K
w0m27sq
29 Jun 20
Annual report
4:02pm
10-K
EX-10.2
h7wr9bs2c
29 Jun 20
Annual report
4:02pm
S-3
snvbrfjx8y0lg m6cu
29 Jun 20
Shelf registration
12:00am
8-K
EX-99.1
ss4n8rnyi1bjkzpa
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm